Search

Lightweight polyamide composites and structures have been widely studied and employed in several industrial sectors. In this study, the development of a nanocomposite of polyamide 6 and graphene oxide (PA6‐GO) by melt‐compounding and the joining with aluminum alloy AA6061 through direct‐adhesion injection overmolding are addressed. PA6‐GO nanocomposite exhibited well‐dispersed thin (300 nm) GO platelets distributed within the PA6 matrix, which resulted in an increase of 21% in the tensile modulus and 16% in the yield stress for a filler loading of 0.5 wt%. PA6‐GO/AA6061 hybrid joints showed good mechanical anchorage through the complete filling of the polymer into micro‐scale grooves designed onto the metal surface, which ensured outstanding shear strength of 7.1 ± 1.0 MPa, comparable to other polyamide‐metal hybrid joints reported in the literature. This indicates that the processing routes and materials developed are promising for lightweight engineering applications. Highlights: A PA6‐GO nanocomposite with enhanced tensile properties was developed.A joint of PA6‐GO and AA6061 with outstanding shear strength was obtained.Fast and efficient melt‐processing routes were employed.These materials are promising for lightweight engineering applications. [ABSTRACT FROM AUTHOR]

Purpose: To determine whether intra-articular injections of peripheral blood stem cells (PBSC) with hyaluronan (HA)-based scaffold improve articular cartilage regeneration in chondral injuries caused by mixed-femoroacetabular impingement syndrome (FAIS) over a period longer than 24 months post-hip arthroscopy., Methods: In this prospective cohort study, patients with mixed-FAIS and chondral injury ≥ IIIB according to the International Cartilage Regeneration and Joint Preservation Society grade or III/IV of Konan/Haddad classification underwent intra-articular injection of PBSC with an HA-based scaffold and micro-drillings during hip arthroscopy. The degree of chondral repair was measured at baseline and 5 years using the International Cartilage Repair Society morphologic score system (MSS) as the primary outcome. Pain was measured at baseline and 5 years using the Visual Analogue Scale for Pain (VAS Pain), and hip functionality was measured at baseline (presurgery), 6 months, 1 year, and 5 years using the Hip Outcome Score (HOS). The largest diameter of injury, median follow-up, side effects, complications, and improvements were described. T -test, ANOVA with multiple comparisons, and statistical power were estimated., Results: From initially 34 cases, 25 patients were enrolled. The median follow-up was 5.1 ± 0.3 years. One patient (4%) reported a few side effects with filgrastim administration. No infection, tumours, or synovitis was reported. The largest diameters in zones two, three, and four were 12.4 ± 3.1 mm ( n  = 8), 13.5 ± 2.8 mm ( n  = 14), and 11.4 ± 1.9 mm ( n  = 3), respectively. Ninety-two percent (23/25) of patients improved their outcomes. The MSS and HOS increased from 3.8 ± 1.1 to 9.6 ± 1.5 pts ( p  < 0.001) and from 65.5 ± 13.0 to 93.9 ± 2.4 pts ( p  < 0.001), respectively. The VAS-Pain decreased from 5.3 ± 0.7 to 1.3 ± 0.6 mm ( p  < 0.001). The obtained a posteriori power-size was 0.99., Conclusion: The intervention suggests a favourable impact on articular cartilage regeneration and clinical outcomes for hip chondral lesions in mixed-FAIS injuries after a median follow-up of 5.1 ± 0.3 years., Level of Evidence: Level IV., Competing Interests: The authors declare no conflict of interest., (© 2024 The Author(s). Journal of Experimental Orthopaedics published by John Wiley & Sons Ltd on behalf of European Society of Sports Traumatology, Knee Surgery and Arthroscopy.)